Local warehouses. Local dispatch. Australia · Canada · USA
Aurelis branded vials and pen-kit presentation for the Sermorelin profile

Branded vial and pen-kit presentation. Confirm the available format, contents and packaging for this product.

Growth hormone signalling

Sermorelin

A 29-amino-acid GHRH analogue used in growth hormone signalling research.

Listed content per unit
10 mg
Presentation
Vial presentation
Local dispatch markets
Australia · Canada · USA
Availability
Confirm by strength & location
Documentation
Request product & batch records

For qualified research enquiries. Listed content is not a dose or administration instruction.

Compound profile

The research context

Sermorelin is GHRH(1–29)-amide, a fragment of growth hormone-releasing hormone. It is used in research relating to pituitary growth-hormone release and endocrine signalling.

Evidence & product context

A mechanistic role in hormone signalling does not establish a general anti-ageing or muscle-building benefit. Batch-specific material specifications remain essential.

What does Sermorelin do?

Read our Sermorelin guide for a simple explanation of growth-hormone research and what studies found.

For a direct comparison of the peptide identities, research pathways and catalogue presentations, read our Ipamorelin vs Sermorelin guide.

What to include in your enquiry

Tell us your required compound, strength, presentation and destination country. If you have a particular analytical requirement, include the method or document you need so the team can match your request to the relevant specification.

Selected scientific references

These sources describe published research or a specific regulated medicine. They are not certificates for an Aurelis batch.

Connect with Aurelis

Your next enquiry
starts with the details.

Tell us the compound, listed content, preferred presentation and destination. Our team can discuss local availability and the documentation for your selected material.